London, United Kingdom

Bradley McColl


Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Victoria, AU (2009)
  • London, GB (2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Bradley McColl

Introduction

Bradley McColl is an esteemed inventor based in London, GB, known for his significant contributions to the field of medical technology. With a total of two patents to his name, McColl has focused on advancing methods for enhancing vascular health through innovative pharmaceutical compositions.

Latest Patents

His latest patents include groundbreaking work on "Methods for inhibiting VEGF-D," which elaborates on methods for activating endothelial growth factors such as VEGF-C or VEGF-D using plasmin. This invention provides methods of treatment through the administration of pharmaceutical compositions that comprise plasmin. Additionally, McColl's patents encompass methods for screening inhibitors that block the activation of these growth factors by plasmin. Another key aspect of his work is the development of inhibitors of plasmin activity, which may offer new therapeutic avenues for patients in need.

Career Highlights

McColl's career has been tightly interwoven with Vegenics Limited, a company dedicated to pioneering research in the field of vascular biology. His work not only demonstrates his innovative spirit but also highlights his commitment to improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, McColl has collaborated with notable colleagues including Megan E. Baldwin and Marc Gregory Achen. These partnerships have likely fostered an environment of creativity and innovation, driving the development of critical medical treatments that have potential applications in various therapeutic areas.

Conclusion

Bradley McColl exemplifies the qualities of a dedicated inventor aimed at transforming medical practices through innovation. His patents reflect a deep understanding of vascular biology and offer promising avenues for future research and patient care. Through his work at Vegenics Limited and collaborations with esteemed colleagues, McColl continues to contribute substantially to the field of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…